Search

everythinglearnresearchcommunity

for

Search:↓

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

TCDD reduces EGF receptor activity and causes various developmental changes in animals.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

Disruption of glycinergic circuits increases pain sensitivity, suggesting new pain treatment options.

Four-amino acid part makes enzyme sensitive to finasteride.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Primary care doctors need to monitor JAK and TYK-2 inhibitors carefully for skin conditions.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

Early diagnosis and treatment are crucial to prevent permanent hair loss from TNFα inhibitors in scalp psoriasis.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Removing both Atr and Trp53 genes in adult mice causes severe tissue damage and death due to DNA damage.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Low-level laser therapy can help with inflammation but isn't widely accepted yet.

Botox can help prevent hair loss by blocking cell death in scalp cells.

Multitarget drugs are needed to better treat complex diseases.

Blocking IL-8 can reduce skin rashes from cancer treatment.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

CTHRC1 is essential for healing and preventing heart rupture after a heart attack.

AL136131.3 slows hair growth by affecting energy processes in hair loss.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Traditional Chinese medicine may help treat ischemic stroke by targeting specific genes and pathways.